Does remote ischaemic preconditioning reduce heart and cerebral damage following carotid endarterectomy? A randomised controlled trial

ISRCTN ISRCTN98544942
DOI https://doi.org/10.1186/ISRCTN98544942
Secondary identifying numbers N/A
Submission date
15/12/2005
Registration date
13/01/2006
Last edited
17/08/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Mr Michael Gaunt
Scientific

Consultant Vascular Surgeon
Level 7
Box 201
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 2QQ
United Kingdom

Phone +44 (0)123 212246
Email michael.gaunt@addenbrookes.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study hypothesisCarotid endarterectomy is associated with a significant risk of stroke or myocardial infarction. This trial aims to determine whether remote ischaemic preconditioning reduces subclinical cerebral and myocardial damage among patients undergoing carotid endarterectomy.
Ethics approval(s)Reviewed and approved by an NHS Research Ethics Committee November 2005. The committee will review the results of the first 12 block randomised patients to determine if the trial should proceed any further.
ConditionCarotid stenosis
InterventionPatients randomised to undergo ischaemic preconditioning will have a thigh cuff inflated on one leg until flow in the pedal arteries disappears. After five minutes have elapsed, the cuff will be moved to the opposite thigh. The cycle will be repeated so that each leg has two five minute periods of ischaemia followed by five minutes of reperfusion.
Control: no ischaemic preconditioning.
Intervention typeOther
Primary outcome measurePrimary neurological outcome: proportion of patients developing a significant change in saccadic latency as determined by quantitative oculometry.
Cardiac outcome: serial troponin I levels post-operatively.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2006
Overall study end date01/01/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants70
Participant inclusion criteriaPatients undergoing elective carotid endarterectomy.
Participant exclusion criteria1. Patients with an ankle-brachial pressure index less than 0.7
2. Patients who have undergone previous lower limb amputation
3. Blind patients
Recruitment start date01/01/2006
Recruitment end date01/01/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Consultant Vascular Surgeon
Cambridge
CB2 2QQ
United Kingdom

Sponsor information

Cambridge University Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

R&D Office
Box 146
Addenbrooke's Hospital
Hills Road
Cambridge
CB2 2QQ
England
United Kingdom

Phone +44 (0)1223 274486
Email joanne.heritage@addenbrookes.nhs.uk
Website http://www.addenbrookes.nhs.uk
ROR logo "ROR" https://ror.org/04v54gj93

Funders

Funder type

Charity

Cambridge Vascular Research Fund (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2010 Yes No